Prudential Financial Inc Ikena Oncology, Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 18,200 shares of IKNA stock, worth $24,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,200
Previous 29,800
38.93%
Holding current value
$24,024
Previous $51,000
43.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
54Shares Held
31.8MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.62 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.4 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.29 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.73 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.67 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $47.9M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...